CD14分子(CD14)活性蛋白
Active Cluster Of Differentiation 14 (CD14)
Monocyte differentiation antigen CD14; Myeloid cell-specific leucine-rich glycoprotein
- 編號(hào)APA685Hu01
 - 物種Homo sapiens (Human,人)相同的名稱,不同的物種。
 - 緩沖液成份20mM Tris, 150mM NaCl緩沖液(pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300)
 - 性狀凍干粉
 - 純度> 97%
 - 等電點(diǎn)8.5
 - 應(yīng)用Cell?culture;?Activity?Assays.
 - 下載英文說明書 中文說明書
 - 規(guī)格10μg50μg200μg1mg5mg
 - 價(jià)格¥ 2016¥ 5040¥ 10080¥ 30240¥ 75600
 - 欲了解實(shí)際交易價(jià)格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
 
活性實(shí)驗(yàn)

Figure. The binding activity of CD14 with LBP.
Cluster Of Differentiation 14 (CD14), also known as CD14, is a component of the innate immune system. CD14 acts as a co-receptor (along with the Toll-like receptor TLR 4 and MD-2) for the detection of bacterial lipopolysaccharide (LPS). CD14 can bind LPS only in the presence of lipopolysaccharide-binding protein (LBP). Although LPS is considered its main ligand, CD14 also recognizes other pathogen-associated molecular patterns such as lipoteichoic acid. Besides, Lipopolysaccharide Binding Protein (LBP) has been identified as an interactor of CD14, thus a binding ELISA assay was conducted to detect the interaction of recombinant human CD14 and recombinant human LBP. Briefly, CD14 were diluted serially in PBS with 0.01% BSA (pH 7.4). Duplicate samples of 100μL were then transferred to LBP-coated microtiter wells and incubated for 2h at 37℃. Wells were washed with PBST and incubated for 1h with anti-CD14 pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody, wells were aspirated and washed 3 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50μL stop solution to the wells and read at 450nm immediately. The binding activity of CD14 and LBP was shown in Figure 1, and this effect was in a dose dependent manner.

CD14 also can enhance LPS-stimulated IL-8 secretion by THP-1 human acute monocytic leukemia cells. Therefore, THP1 cells were cultured in 24 well plates at a concentration of 106 cells/mL and stimulated by LPS (1μg/mL), then added of different concentrations of recombinant human CD14 (1μg/mL, 5μg/mL). After 24h later, the production of IL8 was determined in the supernatants by cytokine specific ELISA.
Result: When the concentration of CD14 was 5μg/mL, the secretion LPS-stimulated IL-8 can be significantly increased.

The standard curve was demonstrated as follows.

Figure. Effects of CD14 on IL8 production by THP1?cells.
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過一個(gè)月,-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) | 
| EPA685Hu62 | CD14分子(CD14)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| APA685Hu62 | CD14分子(CD14)活性蛋白 | Cell?culture;?Activity?Assays. | 
| APA685Hu01 | CD14分子(CD14)活性蛋白 | Cell?culture;?Activity?Assays. | 
| RPA685Hu02 | CD14分子(CD14)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| RPA685Hu01 | CD14分子(CD14)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| APA685Hu61 | CD14分子(CD14)活性蛋白 | Cell?culture;?Activity?Assays. | 
| EPA685Hu61 | CD14分子(CD14)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| EPA685Hu64 | CD14分子(CD14)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| PAA685Hu01 | CD14分子(CD14)多克隆抗體 | WB; IHC; ICC; IP. | 
| PAA685Hu06 | CD14分子(CD14)多克隆抗體 | WB; IHC; ICC; IP. | 
| PAA685Hu02 | CD14分子(CD14)多克隆抗體 | WB; IHC | 
| FAA685Hu01 | 抗CD14分子(CD14)多克隆抗體 | Flow cytometry. | 
| FAA685Hu03 | 抗CD14分子(CD14)多克隆抗體 | Flow cytometry. | 
| LAA685Hu71 | CD14分子(CD14)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. | 
| MAA685Hu27 | CD14分子(CD14)單克隆抗體 | WB; IHC; ICC; IP. | 
| MAA685Hu29 | CD14分子(CD14)單克隆抗體 | WB; IHC; ICC; IP. | 
| MAA685Hu23 | CD14分子(CD14)單克隆抗體 | WB; IHC; ICC; IP. | 
| MAA685Hu22 | CD14分子(CD14)單克隆抗體 | WB; IHC; ICC; IP. | 
| MAA685Hu21 | CD14分子(CD14)單克隆抗體 | WB; IHC; ICC; IP. | 
| MAA685Hu24 | CD14分子(CD14)單克隆抗體 | WB; IHC; ICC; IP. | 
| MAA685Hu25 | CD14分子(CD14)單克隆抗體 | WB; IHC; ICC; IP. | 
| MAA685Hu26 | CD14分子(CD14)單克隆抗體 | WB; IHC; ICC; IP. | 
| MAA685Hu28 | CD14分子(CD14)單克隆抗體 | WB | 
| RAA685Hu25 | CD14分子(CD14)重組抗體 | WB; IF; ICC; IHC; IP; FCM. | 
| FAA685Hu02 | 抗CD14分子(CD14)單克隆抗體 | FCM | 
| FAA685Hu08 | 抗CD14分子(CD14)單克隆抗體 | Flow cytometry. | 
| FAA685Hu06 | 抗CD14分子(CD14)單克隆抗體 | Flow cytometry. | 
| FAA685Hu04 | 抗CD14分子(CD14)單克隆抗體 | Flow cytometry. | 
| FAA685Hu86 | 抗CD14分子(CD14)單克隆抗體(異硫氰酸熒光素標(biāo)記) | FCM | 
| SEA685Hu | CD14分子(CD14)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| LMA685Hu | CD14分子(CD14)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. | 
| KSA685Hu01 | CD14分子(CD14)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | Main materials for "Do It (ELISA Kit) Yourself". | 
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) | 
| Journal of Pharmacology and Experimental Therapeutics | Successful Treatment of Acute Lung Injury with Pitavastatin in Septic Mice: Potential Role of Glucocorticoid Receptor Expression in Alveolar Macrophages[Aspet: 171462] | 
| Tumour Biol | Elevated serum soluble CD15 levels in chronic HBV infection are significantly associated with HBV-related hepatocellular carcinoma[PubMed: 26643894] | 
| Free Patents online | RHEUMATOID ARTHRITIS RELATED BIOMARKER[20170350884] | 
| Intensive Care Research | Evaluating the Roles of sCD14 and sCD14-ST in Diagnosing COPD and Predicting an Acute Exacerbation of COPD[] | 





